
Provider review
Eve review
Genuinely women's-health-focused — LegitScript status not confirmable
A genuinely women's-focused platform offering compounded and brand GLP-1s on one account, with nothing charged unless a physician approves you. Our last check put compounded care from $195 a month; we could not find a price or a LegitScript badge on the live site.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Eve fills a real, distinctive gap — women's-health-focused GLP-1 care with both compounded and brand-name options on one account, plus a genuinely reader-friendly "$0 unless approved" payment model. At our last check, pricing starts around $195/mo and the site carries a LegitScript ID, though we could not confirm either — worth checking directly before enrolling, since it's not clear whether that reflects a site change or content we simply did not reach. No compounding pharmacy, medical director, or legal entity is named anywhere either way.
Eve is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You want a platform built specifically around women's health rather than a gender-neutral one
- You want both compounded and brand-name GLP-1 options on a single account
- You want a "pay nothing unless approved" model rather than paying upfront
Look elsewhere if
- You want a LegitScript badge confirmed on the same visit you check pricing
- You want a named compounding pharmacy, medical director, or legal entity
- You want the full list of states served published before starting
What it actually costs
What they advertise
Compounded semaglutide from $195/mo, at our last check.
What you actually pay, month to month
$195/mo is the figure from our last check; we found no specific price to independently confirm it.
Checked live on Eve's own site at https://www.tryeve.co in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Eve bundles in, and what it does not.
Clinician consult
"$0 unless approved by a licensed physician" evaluation model.
Bloodwork / labs
Not published.
Follow-ups and dose changes
No cadence published.
Human support
Not published.
Injection supplies
Not itemized.
Shipping
No terms published.
Pharmacy, labs and oversight
The pharmacy
Not named anywhere.
Oversight
No cadence published.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
Not published.
The honest cons
The part they would rather you skipped
Eve's reader-friendly "$0 unless approved" model and dual compounded/brand-name lineup are both genuinely reader-friendly — but we could not find a LegitScript badge, a specific price, or a named compounding pharmacy anywhere on the pages we read, so the strongest of our last check's claims about this provider aren't re-checked here.
- LegitScript badge not found on any page we read — not re-checked
- Specific pricing not found on any page we read — resting on our last check
- Compounding pharmacy not named anywhere
- Named medical director or corporate legal entity not disclosed
None of this is unique to Eve — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. Eve is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does

- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate

- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to

13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Eve's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Eve's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.